TrianglePUBLICATIONS · 29507077
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2018 May 10
- First author
- Fanale MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Fanale MA
- type
- Author
- name
- Horwitz SM
- type
- Author
- name
- Forero-Torres A
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Advani RH
- type
- Author
- name
- Pro B
- type
- Author
- name
- Chen RW
- type
- Author
- name
- Davies A
- type
- Author
- name
- Illidge T
- type
- Author
- name
- Uttarwar M
- type
- Author
- name
- Lee SY
- type
- Author
- name
- Ren H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fanale MA
- type
- Author
- name
- Horwitz SM
- type
- Author
- name
- Forero-Torres A
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Advani RH
- type
- Author
- name
- Pro B
- type
- Author
- name
- Chen RW
- type
- Author
- name
- Davies A
- type
- Author
- name
- Illidge T
- type
- Author
- name
- Uttarwar M
- type
- Author
- name
- Lee SY
- type
- Author
- name
- Ren H
- type
- Author
- bibliography ids
- nci-bib-d00c06883853870b8a3f6b97
- book metadata
- content sha256
- 7d788a4113808c160af1fc26a98f0524dd5e4931085916debb5d4ac25598741c
- document type
- citation
- dois
- 10.1182/blood-2017-12-821009
- electronic publication date
- display
- 2018 Mar 5
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29507077
- immutable id
- pubmed:29507077@7d788a4113808c160af1fc26a98f0524dd5e4931085916debb5d4ac25598741c
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 19
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2120-2124
- volume
- 131
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29507077
- provenance
- batch id
- ec9444d0f4cade22eb9f
- provider
- NCBI PubMed ESummary
- record sha256
- 7b2ec9f4e9f9c2b58b7edf80b659ba7477198dc45671761421f5a71fdb54eb51
- response sha256
- 6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
- retrieved at
- 2026-09-09T23:47:30.975610+00:00
- publication date
- display
- 2018 May 10
- precision
- day
- year
- 2018
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.
Preserved source evidence · Independent clinical review pending · Not medical advice